C
Cheryl M. Reichert
Researcher at National Institutes of Health
Publications - 23
Citations - 5080
Cheryl M. Reichert is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Antibody & Immunotherapy. The author has an hindex of 18, co-authored 23 publications receiving 4973 citations.
Papers
More filters
Journal ArticleDOI
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
Steven A. Rosenberg,Michael T. Lotze,Linda M. Muul,Susan F. Leitman,Alfred E. Chang,S. E. Ettinghausen,Yvedt L. Matory,John M. Skibber,Eitan Shiloni,John T. Vetto,Claudia A. Seipp,Colleen Simpson,Cheryl M. Reichert +12 more
TL;DR: Preliminary results of the systemic administration of autologous lymphokine-activated killer (LAK) cells and the recombinant-derived lymphokin interleukin-2 to patients with advanced cancer are described, based on animal models in which this regimen mediated the regression of established pulmonary and hepatic metastases from a variety of murine tumors in several strains of mice.
Journal ArticleDOI
Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.
TL;DR: It appears that the mechanism of the antitumor effect of recombinant IL-2 administered systemically is via the generation of LAK cells in vivo, although this hypothesis remains to be proven.
Journal Article
Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors.
Anthony L. Asher,James J. Mulé,Attan Kasid,Nicholas P. Restifo,J. C. Salo,Cheryl M. Reichert,Gitie Jaffe,B. Fendly,M. Kriegler,Steven A. Rosenberg +9 more
TL;DR: TNF-producing tumor cells could function in a paracrine fashion by inhibiting the growth of unmodified, parental tumor cells implanted at the same site and this process requires the existence of intact host immunity.
Journal Article
Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
Lawrence Tamarkin,Michael Cohen,David Roselle,Cheryl M. Reichert,Marc E. Lippman,Bruce A. Chabner +5 more
TL;DR: The hypothesis that melatonin inhibits the development of DMBA-induced mammary tumors in the rat while removal of the pineal gland stimulates development of such tumors is supported.
Journal ArticleDOI
Ophthalmic Involvement in Acquired Immunodeficiency Syndrome
Alan G. Palestine,Merlyn M. Rodrigues,Abe M. Macher,Chi-Chao Chan,H. Clifford Lane,Anthony S. Fauci,Henry Masur,Dan L. Longo,Cheryl M. Reichert,Ronald G. Steis,Alain H. Rook,Robert B. Nussenblatt +11 more
TL;DR: Twenty patients with acquired immunodeficiency syndrome (AIDS) died and the eyes were obtained for culture and histopathologic examination, and cytomegalovirus retinitis was a significant cause of visual loss.